STOCK TITAN

Cabaletta Bio (CABA) Free Cash Flow by Year

CABA NASDAQ

Cabaletta Bio, Inc. recorded an outflow of $132.3M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to an outflow of $162.5M in free cash flow. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Cabaletta Bio, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$132.3M
YoY n/m
5Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CABA Free Cash Flow by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Free Cash Flow-$162.5M-$132.3Mn/m-$90.4Mn/m-$54.2Mn/m-$48.8Mn/m-$35.3Mn/m-$27.4Mn/m-$16.7MN/A

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

CABA Free Cash Flow by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Free Cash Flow-$42.9Mn/m-$41.5Mn/m-$42.6Mn/m-$35.5Mn/m-$34.6Mn/m-$30.6Mn/m-$31.6Mn/m-$23.5Mn/m-$20.6Mn/m-$21.6Mn/m-$24.8Mn/m-$16.6Mn/m

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Cabaletta Bio, Inc. financials

Frequently Asked Questions

Cabaletta Bio, Inc. recorded an outflow of $132.3M in free cash flow in fiscal year 2025.

Cabaletta Bio, Inc. (CABA) reported an outflow of $90.4M in free cash flow in fiscal year 2024 and an outflow of $132.3M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Cabaletta Bio, Inc. (CABA) reported an outflow of $162.5M in free cash flow over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Cabaletta Bio, Inc. (CABA) reported -$42.9M in free cash flow in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Cabaletta Bio, Inc. (CABA) reported on that line in every period on record.